TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 66 filers reported holding TG THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,000 | -16.7% | 120 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -96.7% | 120 | -96.6% | 0.00% | -100.0% |
| Q4 2020 | $183,000 | +94.7% | 3,510 | -0.3% | 0.01% | +120.0% |
| Q3 2020 | $94,000 | -87.8% | 3,520 | -95.7% | 0.01% | -82.1% |
| Q2 2014 | $770,000 | -42.7% | 81,989 | -57.9% | 0.03% | -45.1% |
| Q1 2014 | $1,343,000 | +75.1% | 194,701 | -1.0% | 0.05% | +75.9% |
| Q4 2013 | $767,000 | – | 196,684 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |